Literature DB >> 23152563

Suppressors of cytokine signaling promote Fas-induced apoptosis through downregulation of NF-κB and mitochondrial Bfl-1 in leukemic T cells.

Jiyoung Oh1, Seol-Hee Kim, Sinae Ahn, Choong-Eun Lee.   

Abstract

Suppressors of cytokine signaling (SOCS) are known as negative regulators of cytokine- and growth factor-induced signal transduction. Recently they have emerged as multifunctional proteins with regulatory roles in inflammation, autoimmunity, and cancer. We have recently reported that SOCS1 has antiapoptotic functions against the TNF-α- and the hydrogen peroxide-induced T cell apoptosis through the induction of thioredoxin, which protects protein tyrosine phosphatases and attenuates Jaks. In this study, we report that SOCS, on the contrary, promote death receptor Fas-mediated T cell apoptosis. The proapoptotic effect of SOCS1 was manifested with increases in Fas-induced caspase-8 activation, truncated Bid production, and mitochondrial dysfunctions. Both caspase-8 inhibitor c-Flip and mitochondrial antiapoptotic factor Bfl-1 were significantly reduced by SOCS1. These proapoptotic responses were not associated with changes in Jak or p38/Jnk activities but were accompanied with downregulation of NF-κB and NF-κB-dependent reporter gene expression. Indeed, p65 degradation via ubiquitination was accelerated in SOCS1 overexpressing cells, whereas it was attenuated in SOCS1 knockdown cells. With high NF-κB levels, the SOCS1-ablated cells displayed resistance against Fas-induced apoptosis, which was abrogated upon siBfl-1 transfection. The results indicate that the suppression of NF-κB-dependent induction of prosurvival factors, such as Bfl-1 and c-Flip, may serve as a mechanism for SOCS action to promote Fas-mediated T cell apoptosis. SOCS3 exhibited a similar proapoptotic function. Because both SOCS1 and SOCS3 are induced upon TCR stimulation, SOCS would play a role in activation-induced cell death by sensitizing activated T cells toward Fas-mediated apoptosis to maintain T cell homeostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23152563     DOI: 10.4049/jimmunol.1103415

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Silencing of ZNF139-siRNA induces apoptosis in human gastric cancer cell line BGC823.

Authors:  Liqiao Fan; Bibo Tan; Yong Li; Qun Zhao; Yü Liu; Dong Wang; Zhidong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 2.  The Importance of Dendritic Cells in Maintaining Immune Tolerance.

Authors:  Cindy Audiger; M Jubayer Rahman; Tae Jin Yun; Kristin V Tarbell; Sylvie Lesage
Journal:  J Immunol       Date:  2017-03-15       Impact factor: 5.422

3.  NF-κB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity.

Authors:  Alejandra G Erlejman; Sonia A De Leo; Gisela I Mazaira; Alejandro M Molinari; María Fernanda Camisay; Vanina Fontana; Marc B Cox; Graciela Piwien-Pilipuk; Mario D Galigniana
Journal:  J Biol Chem       Date:  2014-08-07       Impact factor: 5.157

4.  H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.

Authors:  Amy V Paschall; Dafeng Yang; Chunwan Lu; Jeong-Hyeon Choi; Xia Li; Feiyan Liu; Mario Figueroa; Nicholas H Oberlies; Cedric Pearce; Wendy B Bollag; Asha Nayak-Kapoor; Kebin Liu
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

5.  Genistein Protects Against Ox-LDL-Induced Inflammation Through MicroRNA-155/SOCS1-Mediated Repression of NF-ĸB Signaling Pathway in HUVECs.

Authors:  Huaping Zhang; Zhenxiang Zhao; Xuefen Pang; Jian Yang; Haixia Yu; Yinhong Zhang; Hui Zhou; Jiahui Zhao
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

Review 6.  MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.

Authors:  Amir Abbas Hamidi; Negin Taghehchian; Zahra Basirat; Amir Sadra Zangouei; Meysam Moghbeli
Journal:  Biomark Res       Date:  2022-06-04

7.  SOCS3 silencing attenuates eosinophil functions in asthma patients.

Authors:  Ma Paz Zafra; Jose A Cañas; Carla Mazzeo; Cristina Gámez; Veronica Sanz; Mar Fernández-Nieto; Santiago Quirce; Pilar Barranco; Javier Ruiz-Hornillos; Joaquín Sastre; Victoria del Pozo
Journal:  Int J Mol Sci       Date:  2015-03-10       Impact factor: 5.923

8.  Mechanism of suppressors of cytokine signaling 1 inhibition of epithelial-mesenchymal transition signaling through ROS regulation in colon cancer cells: suppression of Src leading to thioredoxin up-regulation.

Authors:  Sung-Hoon Jung; Su-Min Kim; Choong-Eun Lee
Journal:  Oncotarget       Date:  2016-09-20

9.  MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1.

Authors:  Wei Zhang; Wenyue Ji; Xudong Zhao
Journal:  BMC Cancer       Date:  2019-11-12       Impact factor: 4.430

10.  SOCS1 counteracts ROS-mediated survival signals and promotes apoptosis by modulating cell cycle to increase radiosensitivity of colorectal cancer cells.

Authors:  Ji-Yoon Ryu; Jiyoung Oh; Su-Min Kim; Won-Gi Kim; Hana Jeong; Shin-Ae Ahn; Seol-Hee Kim; Ji-Young Jang; Byong Chul Yoo; Chul Woo Kim; Choong-Eun Lee
Journal:  BMB Rep       Date:  2022-04       Impact factor: 5.041

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.